Trials / Completed
CompletedNCT01870674
Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects
A Randomized, Double-blind, Placebo/Active-controlled, Single/Multiple Dose Phase 1 Clinical Study to Investigate the Safety/Tolerability and PK/PD of YH12852 After Oral Administration in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study to evaluate the safety/tolerability and pharmacokinetics/pharmacodynamics(PK/PD)of YH12852 after oral administration in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YH12852 | |
| DRUG | Prucalopride | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2013-06-06
- Last updated
- 2015-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01870674. Inclusion in this directory is not an endorsement.